Guardant Health (GH) Stock Price
$44.97 0%
to add to portfolio
AI Score
-
Alternative
8 -
Fundamental
1 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Guardant Health, AI stock picks, stock alerts and much more.
GH AI Stock Analysis
Financial Performance
Guardant Health's financial performance shows mixed results. The company reported revenue of $191.5M in the last quarter, an increase of 8% from the previous quarter and a year-over-year increase of 23.5%. This indicates solid growth in terms of revenue generation. However, their gross profit was at $117M which is down by -50.5% year over year despite being up by 11.6% from the previous quarter. Their operating income profit stood at -$117.3M, marking a decrease of -16.6% from the previous quarter.
Stock Price
The stock price has shown significant improvement with current trading value at $47.65, up by 37.1% in the last month and impressively up by 117.3% YoY indicating strong investor confidence and market performance.
Alternative Data Signals
The company's web traffic has seen a decline, with monthly visitors reducing by -34.8%, suggesting possibly reduced customer engagement or interest online compared to prior periods.In terms of job openings, there seems to be an upward trend with openings increasing by over 80%, potentially indicating plans for expansion or increased operations.Employee business outlook appears neutral while social media following on platforms like Twitter and Facebook show modest growth.
Conclusion
In summary, Guardant Health presents as a moderately performing stock given its solid revenue growth but declining profits coupled with strong stock price performance offset somewhat by mixed signals from alternative data sources.
Note: This AI Stock Analysis is based on data as of January 30. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Guardant Health (GH) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Guardant Health (GH), currently trading at $44.97, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GH
-
Guardant Health, Inc.
-
Symbol
GH
-
Market
NASDAQ
-
Industry
Medical - Diagnostics & Research
-
Market Cap
5.6B
Similar Stocks
 |
Bionano Genomics BNGO |
$4.05 0.00% |
2 |
 |
Illumina ILMN |
$71.2 3.2% |
4 |
 |
Neogen NEOG |
$4.39 4.6% |
4 |
 |
DarioHealth DRIO |
$0.75 7.1% |
4 |
 |
Idexx Laboratories IDXX |
$411.5 2.3% |
6 |
News
GH Alternative Data
Web Traffic
Guardant Health receives an estimated 64158 monthly visitors to guardanthealth.com.
-
Web Traffic
64158
-
Change from Previous Month
29.9%
-
3 Month Change
21.4%
-
YoY Change
21.4%
Reddit Mentions
Guardant Health has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
News Mentions
Guardant Health was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
100%
-
3 Month Change
0%
Twitter Followers
Guardant Health has 6,142 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
6142
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Facebook Engagement
Guardant Health has engaged 7 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
7
-
Daily Change
53.3%
-
1 Month Change
63.2%
-
3 Month Change
97.6%
-
YoY Change
97.6%
Youtube Subscribers
Guardant Health has 605 subscribers on its main Youtube channel, up by 2% over the last month.
-
Youtube Subscribers
605
-
Daily Change
0.2%
-
1 Month Change
2%
-
3 Month Change
27.4%
-
YoY Change
27.4%
LinkedIn Followers
221,774 are following Guardant Health on LinkedIn, up by 4% over the last month.
-
LinkedIn Followers
221774
-
Daily Change
0.1%
-
1 Month Change
4%
-
3 Month Change
10%
Job Postings
Guardant Health has an estimated 104 open job postings, which is down -1.9% over the last month.
-
Job Postings
104
-
Daily Change
2.8%
-
1 Month Change
1.9%
-
3 Month Change
25.2%
-
YoY Change
25.2%
LinkedIn Employees
According to LinkedIn, Guardant Health has 3,216 employees.
-
LinkedIn Employees
3216
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
3%
-
YoY Change
3%
Business Outlook
According to employee reviews, the business outlook among employees at Guardant Health is 48 out of 100 (neutral).
-
Business Outlook
48
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
GH Financials
GH Key Metrics
-
Total Revenue
$201.8M
-
Net Income
-$111M
-
Earnings per Share
-$0.9
-
Free cash flow
-$83.4M
-
EBITDA
-$99.2M
-
EBITDA Ratio
-0.491497
-
Total Assets
$1.5B
GH 2-year Revenue & Income
GH 2-year Free Cash Flow
GH Technicals
GH SMA
GH RSI
FAQ
What's the current price of Guardant Health (GH) Stock?
The price of an Guardant Health (GH) share is $44.97.
What's the market cap of Guardant Health?
The current market cap of Guardant Health is 5.6B.
Should I buy or sell GH?
Guardant Health shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Guardant Health is better viewed as a hold or accumulate position while waiting for further developments.
Is Guardant Health a good investment?
The current analysis of Guardant Health's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Guardant Health's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Guardant Health (GH) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Guardant Health stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Guardant Health (GH) that investors often compare it to?
Guardant Health (GH) is often compared to similar stocks such as Bionano Genomics, Illumina, Neogen, DarioHealth and Idexx Laboratories.
What is the forecast for Guardant Health's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Guardant Health's stock price to be around $46.86 in 2026. Starting from the current price of $44.97, this represents a 4.2% change in price, indicating a neutral outlook for the stock.
How to buy Guardant Health (GH) Stock?
Guardant Health stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Guardant Health shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.